Skip Navigation LinksHome > January/February 2013 - Volume 19 - Issue 1 > Histologic and Cytologic Effects of Vaginal Estrogen in Wome...
Female Pelvic Medicine & Reconstructive Surgery:
doi: 10.1097/SPV.0b013e318278cc40
Original Article

Histologic and Cytologic Effects of Vaginal Estrogen in Women With Pelvic Organ Prolapse: A Randomized Controlled Trial

Vaccaro, Christine M. DO*; Mutema, George K. MD; Fellner, Angela N. PhD; Crisp, Catrina C. MD§; Estanol, Maria V. MD§; Kleeman, Steven D. MD§; Pauls, Rachel N. MD§

Collapse Box


Objective: This study aimed to evaluate the histologic and cytologic effects of preoperative vaginal estrogen in women with atrophic vaginitis and pelvic organ prolapse.

Methods: Forty-two women with atrophic vaginitis and stage greater than or equal to 2 prolapse were enrolled in this assessor-blinded randomized controlled trial comparing daily vaginal estrogen cream use for 2 to 12 weeks preoperatively versus no intervention. Data were analyzed using t test and analysis of variance.

Results: Of these 42 women, 22 received treatment and 20 were controls. After a mean 7 (3) weeks of use, the vaginal maturity index increased 15.5% in the treatment group and declined 1.5% in the control group (P < 0.001). The vaginal epithelial thickness was 339 (96) μm in the treatment group compared to 302 (119) μm (P = 0.275) in the controls.

Conclusions: Preoperative vaginal estrogen application for 2 to 12 weeks restores vaginal cytology to premenopausal levels, but does not increase vaginal epithelial thickness in women with prolapse.

© 2013 by Wolters Kluwer Health | Lippincott Williams & Wilkins


Article Tools


Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.